KẾT QỦA BƯỚC ĐẦU ÁP DỤNG ECMO - VV ĐIỀU TRỊ BỆNH NHÂN SUY HÔ HẤP CẤP NẶNG TẠI KHOA HỒI SỨC TÍCH CỰC BỆNH VIỆN BỆNH NHIỆT ĐỚI TRUNG ƯƠNG

Abstract

Acute respiratory distress syndrome (ARDS) is a serious disease with a very high mortality rate. Since 2009, ECMO - VV has been widely used in the world to treat severe ARDS patients. The intensive care unit (ICU) of National Hospital of Tropical Diseases (NHTD) began applying ECMO - VV in December 2014 and obtained initial results. Objectives: To evaluate initial results of the application of ECMO-VV in the treatment of severe ARDS patients at ICU - NHTD.

Subjects and Methods: Describe severe series of ARDS pneumonia cases that are applied ECMO-VV at ICU -NHTD.

Results: 16 patients, men accounted for 10/16 patients, the average age was 48 ± 17 years old. Before ECMO - VV, the patient's average SOFA score was 9 ± 5, 100% patients had Murray score > 3.5 points. ECMO cannunlae were placed percutaneously by the Seldinger technique for all the patients. The average ECMO - VV intervention duration is 18 days. The most common complication is bleeding (recorded in 81% of patients).

Results of treatment: 8 patients (50%) stabilized to discharge. ARDS patients due to influenza infection have a higher survival rate than other causes (80% versus 40% and 3%). Conclusions: ECMO - VV is a highly effective technique to treat severe ARDS patients especially with ARDS due to influenza infection.